175 related articles for article (PubMed ID: 24380289)
21. The physicochemical interactive mechanism between nanoparticles and raffinose during freeze-drying.
Kamiya S; Takamatsu H; Sonobe T; Nakashima K
Int J Pharm; 2014 Apr; 465(1-2):97-101. PubMed ID: 24560638
[TBL] [Abstract][Full Text] [Related]
22. Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery.
Alhalaweh A; Andersson S; Velaga SP
Eur J Pharm Sci; 2009 Oct; 38(3):206-14. PubMed ID: 19616094
[TBL] [Abstract][Full Text] [Related]
23. Development of a Soluplus budesonide freeze-dried powder for nasal drug delivery.
Pozzoli M; Traini D; Young PM; Sukkar MB; Sonvico F
Drug Dev Ind Pharm; 2017 Sep; 43(9):1510-1518. PubMed ID: 28425305
[TBL] [Abstract][Full Text] [Related]
24. Increase of the pharmacological and pharmacokinetic efficacy of negatively charged polypeptide recombinant hirudin in rats via parenteral route by association with cationic liposomes.
Meng M; Liu Y; Wang YB; Wang JC; Zhang H; Wang XQ; Zhang X; Lu WL; Zhang Q
J Control Release; 2008 Jun; 128(2):113-9. PubMed ID: 18423766
[TBL] [Abstract][Full Text] [Related]
25. Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation.
Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H
Drug Deliv; 2009 Apr; 16(3):167-75. PubMed ID: 19514977
[TBL] [Abstract][Full Text] [Related]
26. The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process.
Grohganz H; Lee YY; Rantanen J; Yang M
Int J Pharm; 2013 Apr; 447(1-2):224-30. PubMed ID: 23500620
[TBL] [Abstract][Full Text] [Related]
27. Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution.
Ohshima H; Miyagishima A; Kurita T; Makino Y; Iwao Y; Sonobe T; Itai S
Int J Pharm; 2009 Jul; 377(1-2):180-4. PubMed ID: 19446623
[TBL] [Abstract][Full Text] [Related]
28. Optimized pulmonary gene transfection in mice by spray-freeze dried powder inhalation.
Mohri K; Okuda T; Mori A; Danjo K; Okamoto H
J Control Release; 2010 Jun; 144(2):221-6. PubMed ID: 20184930
[TBL] [Abstract][Full Text] [Related]
29. Effect on the nasal bioavailability of co-processing drug and bioadhesive carrier via spray-drying.
Coucke D; Vervaet C; Foreman P; Adriaensens P; Carleer R; Remon JP
Int J Pharm; 2009 Sep; 379(1):67-71. PubMed ID: 19539738
[TBL] [Abstract][Full Text] [Related]
30. Solid-state nanoparticle coated emulsions for encapsulation and improving the chemical stability of all-trans-retinol.
Ghouchi-Eskandar N; Simovic S; Prestidge CA
Int J Pharm; 2012 Feb; 423(2):384-91. PubMed ID: 22210001
[TBL] [Abstract][Full Text] [Related]
31. Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles.
Zhang X; Zhang H; Wu Z; Wang Z; Niu H; Li C
Eur J Pharm Biopharm; 2008 Mar; 68(3):526-34. PubMed ID: 17881202
[TBL] [Abstract][Full Text] [Related]
32. [The nasal mucosa permeability and toxicity of baicalin carrier systems liposomes, beta-cyclodextrin inclusion compound, and phospholipid complex].
Wu PJ; Xu RC; Su ZT; Wei P; Lin YJ; Yang M; Zheng Q
Yao Xue Xue Bao; 2009 Apr; 44(4):417-24. PubMed ID: 19545062
[TBL] [Abstract][Full Text] [Related]
33. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery.
Kumar M; Pandey RS; Patra KC; Jain SK; Soni ML; Dangi JS; Madan J
Int J Biol Macromol; 2013 Oct; 61():189-95. PubMed ID: 23831532
[TBL] [Abstract][Full Text] [Related]
35. Freeze-dried chitosan/pectin nasal inserts for antipsychotic drug delivery.
Luppi B; Bigucci F; Abruzzo A; Corace G; Cerchiara T; Zecchi V
Eur J Pharm Biopharm; 2010 Aug; 75(3):381-7. PubMed ID: 20434556
[TBL] [Abstract][Full Text] [Related]
36. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies.
Sintov AC; Levy HV; Botner S
J Control Release; 2010 Dec; 148(2):168-76. PubMed ID: 20709120
[TBL] [Abstract][Full Text] [Related]
37. Influence of deposition and spray pattern of nasal powders on insulin bioavailability.
Pringels E; Callens C; Vervaet C; Dumont F; Slegers G; Foreman P; Remon JP
Int J Pharm; 2006 Mar; 310(1-2):1-7. PubMed ID: 16427222
[TBL] [Abstract][Full Text] [Related]
38. Glucose cryoprotectant affects glutathione-responsive antitumor drug release from polysaccharide nanoparticles.
Curcio M; Blanco-Fernández B; Costoya A; Concheiro A; Puoci F; Alvarez-Lorenzo C
Eur J Pharm Biopharm; 2015 Jun; 93():281-92. PubMed ID: 25917641
[TBL] [Abstract][Full Text] [Related]
39. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles.
Dyer AM; Hinchcliffe M; Watts P; Castile J; Jabbal-Gill I; Nankervis R; Smith A; Illum L
Pharm Res; 2002 Jul; 19(7):998-1008. PubMed ID: 12180553
[TBL] [Abstract][Full Text] [Related]
40. Chitosan nanoparticles: preparation, size evolution and stability.
Rampino A; Borgogna M; Blasi P; Bellich B; Cesàro A
Int J Pharm; 2013 Oct; 455(1-2):219-28. PubMed ID: 23886649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
